Management of Vomiting in Patients Taking Pregabalin

Antiemetic Selection for Pregabalin-Associated Vomiting

The American Gastroenterological Association recommends using standard antiemetic therapy with 5-HT3 antagonists, such as ondansetron 4-8 mg, or dopamine antagonists, such as prochlorperazine 5-10 mg, as first-line treatment for vomiting in patients taking pregabalin, while continuing pregabalin at the current dose unless toxicity is suspected 1, 2
Ondansetron, a 5-HT3 antagonist, is recommended at 4-8 mg orally 2-3 times daily for nausea and vomiting management in patients taking pregabalin 1, 2
Prochlorperazine, a dopamine antagonist, at 5-10 mg orally or intravenously 3-4 times daily provides effective antiemetic coverage for patients taking pregabalin 1, 3, 2
Metoclopramide at 10-20 mg orally 3-4 times daily offers both antiemetic and prokinetic effects for patients taking pregabalin, though caution is needed with extrapyramidal side effects 1, 2
Promethazine 12.5-25 mg every 4-6 hours can be used as an alternative antiemetic option for patients taking pregabalin, though it carries risk of CNS depression and anticholinergic effects 3
Granisetron, another 5-HT3 antagonist, at 1 mg twice daily or as a 34.3 mg weekly patch provides sustained antiemetic effect for patients taking pregabalin 1
Aprepitant, an NK-1 antagonist, at 80 mg daily may be considered for refractory nausea in patients taking pregabalin, particularly when multiple antiemetic classes have failed 1, 4

Combining a 5-HT3 antagonist with a dopamine antagonist provides approximately 25% relative risk reduction per drug class for patients taking pregabalin 5
If rescue antiemetic treatment is required, use a different class than what was given for prophylaxis for patients taking pregabalin 5
Dexamethasone 4-8 mg can be added as adjunctive therapy, particularly effective for reducing nausea and vomiting without increasing adverse events in patients taking pregabalin 5

Avoid attributing vomiting solely to pregabalin without considering other causes such as underlying gastroparesis, concurrent medications, or gastrointestinal pathology, as recommended by the American Gastroenterological Association 1, 6
Do not use opioid analgesics to manage concurrent pain in patients with vomiting who are taking pregabalin, as opioids further delay gastric emptying and worsen nausea, according to the American Gastroenterological Association 6
Monitor for QTc prolongation when using ondansetron, particularly in patients with cardiac risk factors or on other QT-prolonging medications, as recommended by the American Gastroenterological Association and the American Heart Association 1, 3
Start with lower antiemetic doses in elderly patients due to increased sensitivity to side effects, particularly with dopamine antagonists and benzodiazepines, as recommended by the American Geriatrics Society 2